A Phase 1/2a, Multicenter, Open-Label, First in Human Study to Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Antitumor Activity of DB-1310 in Subjects With Advanced/Metastatic Solid Tumors
NCT05785741 · RECRUITING · Phase 2
We track 1 ClinicalTrials.gov studies led by Dualitybio Inc. The portfolio skews toward Phase 2 (1 trials).
1 clinical trials sponsored by Dualitybio Inc.
| Phase | Trials | Distribution |
|---|---|---|
| Phase 2 | 1 | 100% |
Dualitybio Inc currently sponsors 1 clinical trials tracked on ReadTheTrial. These span Phase 2.
Dualitybio Inc conducts research across multiple therapeutic areas. Browse the trial listings for details.
Yes, Dualitybio Inc currently has 1 trial that are actively recruiting participants. Check individual trial pages for eligibility criteria and locations.